Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 33342-138

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 33342-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30s-daman (30 Daman)

This is a description of a medication product named Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets containing 600 mg Efaverinz, 200 mg Emtricitabine, and 300 mg Tenofovir Disoproxil Fumarate. It was produced by Macloods Pharma USA Inc. in Princeton, NJ. The medication should be dispensed only in its original container and stored at 68°-77°F. It is advised to avoid medications that should not be taken with this product, and the patient information leaflet should be provided with the medication.*

FDA Label Image

Str1 (Str 1)

FDA Label Image

Str2 (Str 2)

FDA Label Image

Str3 (Str 3)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.